PubMed=8908166; DOI=10.1016/S0165-4608(95)00315-0
Iwasaki H., Ohjimi Y., Ishiguro M., Isayama T., Kaneko Y., Yoh S., Emoto G., Kikuchi M.
Epithelioid sarcoma with an 18q aberration.
Cancer Genet. Cytogenet. 91:46-52(1996)

PubMed=10929770; DOI=10.1007/s004030000127
Kusakabe H., Iwasaki H., Sano K., Kiyokane K.
Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
Arch. Dermatol. Res. 292:292-300(2000)

PubMed=16557275; DOI=10.1038/modpathol.3800599
Izumi T., Oda Y., Hasegawa T., Nakanishi Y., Iwasaki H., Sonobe H., Goto H., Kusakabe H., Takahira T., Kobayashi C., Kawaguchi K.-i., Saito T., Yamamoto H., Tamiya S., Iwamoto Y., Tsuneyoshi M.
Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Mod. Pathol. 19:820-831(2006)

PubMed=19756736; DOI=10.1007/s00432-009-0678-1
Hoshino M., Kawashima H., Ogose A., Kudo N., Ariizumi T., Hotta T., Umezu H., Hatano H., Morita T., Nishio J., Iwasaki H., Endo N.
Serum CA 125 expression as a tumor marker for diagnosis and monitoring the clinical course of epithelioid sarcoma.
J. Cancer Res. Clin. Oncol. 136:457-464(2010)